Jongsma MME, Aardoom MA, Cozijnsen MA, van Pieterson M, et al. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial. Gut 2022;71:34-42.
PMID: 33384335